3652 results for «455»
3652 results
Rapid-fire - LAA closure and plugging
17 Feb 2024 – From PCR Tokyo Valves 2024
In this series of rapid-fire case submissions, explore cases of left atrium appendage closure and plugging. Discover compelling cases such as the transcatheter closure of a very late atrial septal defect device erosion, learn about the importance of transseptal puncture during left appendage closure, and more....
The role of WATCHMAN therapy in optimising results and future perspectives
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Boston Scientific will help you understand the latest status and the value of WATCHMAN therapy, as well as learning about future perspectives of LAA closure by new WATCHMAN FLX pro.
Mitral and tricuspid intervention
17 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to discover selected clinical cases regarding complex mitral and tricuspid interventions. Gain insights into phenotypes of secondary tricuspid regurgitation in echocardiography, learn about treatment effectiveness and one-year composite endpoint by clip size of TEER for AFMR, and more!
Primary mitral regurgitation edge to edge repair with one device - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 83-year-old male presented symptomatic severe PMR due to lateral P2 chordal rupture, small LA and preserved LV function (68%). Watch the operators implant one XTW clip successfully.
LIVE case from Sendai Kousei Hospital - Sendai, Japan
Navigate the video by moving your mouse over the chapter icon in...
Rapid-fire - Complications in SHD interventions
17 Feb 2024 – From PCR Tokyo Valves 2024
Learn more about complications related to structural heart disease interventions through this rapid-fire series of cases. Discover cases such as a cardiac arrest due to coronary artery obstruction two days after TAVI using a balloon-expandable valve, an aortic stenosis case switched to surgery due to severe...
TEER for primary mitral regurgitation
18 Feb 2024 – From PCR Tokyo Valves 2024
What are the current indications and future perspectives of using TEER for primary mitral regurgitation? Join this session if you want to gain insight into anatomical evaluation before TEER, learn the procedural strategy for complex primary mitral regurgitation, and explore the specific features of both MitraClip...
Imaging for aortic valve disease
18 Feb 2024 – From PCR Tokyo Valves 2024
Learn about imaging of the aortic valve system in order to better deal with aortic valve disease. Through this series of cases, explore topics such as the impact of implantation depth relative to membranous septum on TAVI outcomes, delve into a meta-analysis exploring the outcomes of...
Rapid-fire - Pulmonary and tricuspid valve implantation
18 Feb 2024 – From PCR Tokyo Valves 2024
In this series of rapid-fire case submissions, gain insight into pulmonary and tricuspid valve implantation. This session explores cases such as a pulmonary valve-in-valve procedure, dealing with tissue valve degeneration, and valve implantation in a calcified RV-PA conduit.
Lifetime management
08 Feb 2025 – From PCR Tokyo Valves 2025
This PCR Tokyo Valves 2025 session explores the latest insights into TAVR explantation. It begins with the management of patients with longer life expectancy, then delves into surgical aortic valve replacement, aortic root enlargement, and commissural alignment—key techniques that may improve reintervention outcomes. The session also...
TAV-in-TAV
08 Feb 2025 – From PCR Tokyo Valves 2025
Watch this PCR Tokyo Valves 2025 session on TAV-in-TAV to discover essential insights on optimizing the procedure. Learn how CT analysis and precise measurements are critical for success, and why coronary protection, chimney stenting, and leaflet modification must be considered in high-risk cases. Experts discuss key...
TAVI complex cases: intravascular hemolysis, Heyde syndrome & more
08 Feb 2025 – From PCR Tokyo Valves 2025
This session presents a diverse array of complex TAVI cases, from interventions for paravalvular leak-induced intravascular hemolysis to cases of severe aortic tortuosity, calcification hindering valve expansion, and successful TAVI in patients with Heyde syndrome and HIV infection. Gain valuable insights into navigating these challenging scenarios.
Post-procedure complications: leaflet thrombus, hemolytic anemia & more
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore this session to discover a range of post-procedure complications that can arise after TAVI, including subacute leaflet thrombus, hemolytic anemia after surgical aortic valve replacement, late migration of papillary fibroelastoma, sinus sequestration, delayed left main occlusion, and high-grade atrioventricular block. Additionally, learn about techniques to...
Redo mitral procedures
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore this session to gain insights into the management of recurrent mitral regurgitation after percutaneous mitral valve interventions. Discover various redo procedures, including the use of the PASCAL system for recurrent MR after MitraClip, redo M-TEER for torn posterior leaflet, and successful redo TEER and MitraClip...
TAV-in-TAV cases
08 Feb 2025 – From PCR Tokyo Valves 2025
Explore this session to delve into the complexities and challenges of TAV-in-TAV procedures. Gain insights into various case studies, including a successful TAV-in-TAV with coronary protection, a case of CABG and TAV-in-TAV, TAVI in a patient with failed homograft and three previous sternotomies, and concurrent mitral...
Standardised implant technique with self-expandable valve
08 Feb 2025 – From PCR Tokyo Valves 2025
Don’t miss this PCR Tokyo Valves 2025 session replay, where leading experts share key techniques for simplifying and optimising TAVI procedures with the Evolut device. This session covers essential insights into safely performing procedures on patients with various anatomical types using the self-expandable valve, while emphasising...
High-risk TAVI
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the management of high-risk TAVI cases in this session. Discover innovative approaches, such as Impella-assisted TAVI in severe bicuspid aortic valve disease with severe left ventricular dysfunction, TAVR for pure native aortic regurgitation in surgically unfit patients, and the use of TAVI as a...
How to optimise clinical outcomes with the latest generation intra-annular self-expandable TAVI device?
08 Feb 2025 – From PCR Tokyo Valves 2025
Discover the latest advancements in TAVI procedures with this PCR Tokyo Valves 2025 session replay, where leading experts share key strategies to enhance patient outcomes. This session explores how to select the optimal index valve for lifetime management, reduce pacemaker rates with the latest intra-annular self-expanding...
The value of WATCHMAN therapy - Who should we treat?
08 Feb 2025 – From PCR Tokyo Valves 2025
Delve into the value of WATCHMAN therapy in this sponsored session by Boston Scientific. Explore the latest evidence and future perspectives of this innovative treatment option. Understand who the ideal patient is for WATCHMAN therapy and how to identify them in daily clinical practice, including TAVI...
Lifetime management - First valve choice matters
08 Feb 2025 – From PCR Tokyo Valves 2025
In this expert-led session, explore new frontiers in TAVI, focusing on bicuspid aortic valves, small annulus, and the risk of secondary interventions. Gain insights from the latest randomized trials (RHEIA) and registry data (CAvEAT), with real-world case discussions highlighting their clinical impact.
Mitral valve-in-valve and valve-in-ring electrosurgery
08 Feb 2025 – From PCR Tokyo Valves 2025
